Todd Berg has a bit of a winning streak going.
Berg worked at three Medtech start-ups prior to accepting the CEO post at exciting new start-upÂ
Metavention, and all three companies would be acquired includingÂ
Torax Medical, the GERD company Berg led from start to finish.
What led Berg to Medtech? Why did he co-found Torax? How did he find success raising capital? How is he approaching his new challenge leading Metavention, which is developing a novel, new potential treatment for type 2 diabetes?
Todd Berg
CEO
Metavention
Mr. Berg brings over twenty-five years of experience with pioneering technologies and a proven track record in funding and marketing early stage start-ups to the Venture Capital and clinical community. He joined Metavention in 2018 after leading Torax Medical, Inc. until its acquisition by Ethicon, Inc., a subsidiary of Johnson & Johnson, Inc.
Prior to Torax Medical, Mr. Berg was with St. Jude Medical where he was the Vice President of Emerging Technology.
Prior positions at St. Jude Medical included General Manager of the Anastomotic Technology Group and Vice President of Research and Development for the Cardiac Surgery Division. He joined St. Jude Medical through the acquisition of Vascular Science in 1999 where he was the Vice President of Research and Development. Prior to Vascular Science he was with SciMed Life Systems and Boston Scientific.
Mr. Berg holds over sixty patents in the area of medical technology and has published numerous articles in professional journals. Mr. Berg has a Bachelor of Science degree in Mechanical Engineering from the University of Minnesota.
